<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02585752</url>
  </required_header>
  <id_info>
    <org_study_id>14-177 / AA-CmfCOPD-02</org_study_id>
    <nct_id>NCT02585752</nct_id>
  </id_info>
  <brief_title>A Study of Expiratory Pressure Modulation in Moderate to Severe COPD Patients - Phase 1b</brief_title>
  <acronym>ComfortCOPD</acronym>
  <official_title>A Study of Expiratory Pressure Modulation in Moderate to Severe COPD Patients - Phase 1b</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ResMed</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ResMed</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Dynamic pulmonary hyperinflation (DH) and intrinsic positive end-expiratory pressure (PEEP)
      are well known problems in COPD patients with acute and chronic respiratory failure.
      Measurement of intrinsic PEEP level during both, invasive and non-invasive ventilation is of
      major importance since in some circumstances (e.g. during exercise or during exacerbations)
      it can significantly increase respiratory workload of COPD patients. Extrinsic PEEP applied
      during both, invasive and noninvasive ventilation is used to overcome intrinsic PEEP and
      therefore to avoid or reduce dynamic hyperinflation.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Low recruitment
  </why_stopped>
  <start_date type="Actual">October 1, 2015</start_date>
  <completion_date type="Actual">November 24, 2017</completion_date>
  <primary_completion_date type="Actual">September 30, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analogue Scale</measure>
    <time_frame>1 day</time_frame>
    <description>Subjective rating of comfort during expiration</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Minute ventilation</measure>
    <time_frame>1 day</time_frame>
    <description>Volume of inhaled air in one minute (L/min)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory rate</measure>
    <time_frame>1 day</time_frame>
    <description>Number of breaths per minute (breaths/min)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tidal volume</measure>
    <time_frame>1 day</time_frame>
    <description>Volume of air that is inhaled or exhaled during normal breathing (mL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CO2 transcutaneous (tcCO2)</measure>
    <time_frame>1 day</time_frame>
    <description>Arterial carbon dioxide partial pressure (mm Hg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pO2 arterial (paO2)</measure>
    <time_frame>1 day</time_frame>
    <description>Arterial oxygen partial pressure (mm Hg)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>Single centre, single arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Noninvasive ventilation with expiratory modulation. Assessment of comfort and blood gases.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Noninvasive ventilation</intervention_name>
    <description>Expiratory pressure modulation</description>
    <arm_group_label>Single centre, single arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age &gt; 18 years who are contractually capable and mentally able to understand and
             follow the instructions of the study personnel

          2. Signed informed consent

          3. Moderate to severe COPD patients (FEV1/FVC ratio &lt;70% and FEV1 &lt; 50% pred) with
             chronic hypercapnic respiratory failure (PaCO2 &gt;45 mmHg)

          4. Currently using NIV

        Exclusion Criteria:

          1. Acute exacerbation of COPD, acute respiratory failure (ph &lt; 7,35 and/or respiratory
             rate &gt;30/min)

          2. Unstable heart failure

          3. Cardiac failure with dehydration

          4. Pregnancy/breastfeeding women

          5. Pneumothorax/-mediastinum

          6. Increased risk of pneumothorax, pneumomediastinum or venous air embolism

          7. In the opinion of the investigator, the patient is unsuitable for the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Dreher, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitätsklinikum Aachen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universitätsklinikum Aachen</name>
      <address>
        <city>Aachen</city>
        <state>Nordrhein-Westfalen</state>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Cornelissen CG, Müller T, Schmitz S, Dreher M. Nichtinvasive Beatmung: Patientenkomfort und Sicherheit einer Modulation des expiratorischen Flusses. Pneumologie 2018; 72(S01), S11</citation>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 20, 2015</study_first_submitted>
  <study_first_submitted_qc>October 22, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 23, 2015</study_first_posted>
  <last_update_submitted>April 19, 2018</last_update_submitted>
  <last_update_submitted_qc>April 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

